Hi All,
I recently left my PE gig to try something more entrepreneurial. I built a thesis around rolling up certain assets in the healthcare industry that trade at low multiples (3-5x) which can be leveraged easily and can trade at up 10x once they generate large enough cashflows.
I managed to raise enough capital to execute the strategy and currently have one asset locked up and ready to get purchased, but I’m starting to get cold feet on the thesis as I am having a harder time than expected finding additional acquisitions. I know it’s highly fragmented and that there is a large amount of these assets, but I’m starting to find out that most are not as good as I thought they would be (i.e. not generating much EBITDA) so I’m not sure how many are valid targets. I'm slightly afraid I might end up getting stuck with only a few assets generating a few 100k in EBITDA and not be able to build to my exit strategy.
I’m looking for someone that has experience in rolling up small assets (100-500k EBITDA) to discuss what I’m doing and bounce some ideas – basically get a rational opinion on if what I’m doing is viable. I’m sure you can understand why I can’t really discuss my cold feet with my team or my stakeholders.
Thanks all,
Ask Martin Shkreli
The problem with things like this is that especially when you're looking at companies that are EBITDA; is that there aren't many synergies.
If you're looking at one particular sub-sector (say med tech). Then sure you can roll up the R&D, implementation, and services all under one roof though those tend to be more expensive to integrate.
Typically from what I've seen, using something like 1 clinic as a hub, and having the drug compounding/ storage/ 3pl services being scalable is what makes it profitable in the long run.
You need to be able to isolate what the highest gross margin components are and see if rolling up another acquisition will scale it or not.
Do you have operators in your team?
For me the biggest amber flag is that you say you find out that some assets are worse than you thought. We rolled up a bunch of EBITDA companies who we knew extremely well and still the re-rating and synergies where worse than we expected (and additional central costs higher than expected). If only one of the assets would have turned out to be a crappy business (concentration, low margin contracts etc.) we would have lost money.
I would only roll up small businesses if you know the businesses inside out and really know what the synergies are. I mean who has to leave, what systems will be replaced. Down to a USD amount.
If you have a platform that has the product and you buy channel its a different story.
EDIT: it wasn't in healthcare but tech enabled / bus services / IT services
The owners are staying on board when we tuck in, we bid around 3.5x and have them roll 1x into the top co as preferred shares and they need to sign agreements to stay on board and manage their business for at least 2 years or face penalties on their rollover shares.
We are allowed to leverage up to 3x with our current debt agreement.. so we can basically buy these businesses without equity. Our investors are only debt for now, until we go after larger targets (1-3M EBITDA), but these trade at higher multiples (4-5x) so ideally we want to start by scrapping up 1-3M EBITDA on our own from these smaller shops before.
Synergies are mostly back office. Its in the service industry so we cant get any economies of scales on COGS. This sounds kinda shit, but I know some companies have done this successfully in the Dental space, which is mostly service also.
EDIT: When I said the assets are worse than I thought, I didnt mean the ones we are buying. I mean the market in general (i.e. we think there are 450 shops in our area and figured about 20% could be strong targets, but turns out it might be more like 5-10%, which may not necessarily be for sale)
I’m currently pursuing a healthcare roll up strategy in a highly fragmented sub sector with 100k-500K EBITDA asset acquisitions (add-ons to platform). I’ve posted a bit about my search fund on the forum regarding some gripes I’ve had with being in the operational side of running the biz. I’d be glad to connect with you and give you my perspective.
Thanks - sent you a PM
Hi, It's two years later, and I've come across your post in this thread. How is your healthcare roll-up going? I'm looking for ideas in the Canadian market if not being done already. Thanks Steve Vancouver
No experience working on rollup healthcare business however, I do have experience operating in the healthcare space. Things you have to account for would be people in a way you don't need to account for them in other types of businesses specifically charging back end software...
I used to do deals for a healthcare roll-up and have an idea of what you're talking about, although I'm guessing we didn't have the exact same strategy. I might be able to fill in some blanks for you. PM me if you want to compare notes.
Some insights I got recently talking to a mid-market M&A banker friend about roll-up's in fragmented industries like healthcare and mid-market retail
+1 SB - this is really good insight. Your second point is very valid. I have about 3-4 deals in play and they always seem to be on the edge of being signed, but they all seem to be waiting for us to close our first deal... its slowly driving me insane.
I've started contacting some of the larger players in hopes of securing a larger asset (a mothership), even if it means paying a bit more (5-6x vs 3-4x). The good news is that we have started building credibility in the market since we have bid vs some of these bigger players. We are basically pitching to these larger players that if we invest in them, we bring our floating deals all at the same time, which to me seems like some solid value add.
EDIT: Forgot to mention that I dont have the capital to acquire one of these larger players yet, but the plan is to get the loi signed and figure out the capital after.. hustle is real.
That's how the big guys in the healthcare space do it. Specifically in the service side, you get a big player in the state that has infrastructure and good payer contracts. You might stretch to a 7x for the right deal. Then when you get the smaller guys in the same state you're giving them 3-4x ebitda but once you roll the contracting into the larger group and consolidate the billed charge schedule that deal becomes a 2-3x for you. You save some money from consolidating back office functions, but that's not really what drives the deals unless you're at a really larger scale. You might be able to find a small player with good contracts too, but you have to know what you're looking for.
I would echo these thoughts.
Main thing for a roll-up strategy is to start with a platform that you then add the smaller pieces onto.
This way, you'll actually get synergies (consolidating suppliers, reduce duplicate management/back office positions), and the value lift is much more tangible (platform trades at 6-10x and you're buying at 3-5x). Furthermore, it's easier to finance the bigger group, and you can often get away with financing your bolt-ons 100% if your original platform is conservatively financed from the get go.
Bingo, you get instant value creation as well from consolidating into the platform because of how each additional dollar gets bought at a lower multiple, then gets re-rated as part of the platform. So even if you don't get huge earnings growth, you already have some returns in the bag.
I've done several multi-site healthcare rollups. Feel free to PM me and we can chat.
Hi mate, I am from Australia and I started a few months ago with all this M&A technique which is fascinating. I would like to ask you a few questions as it seems you know your stuff, would that be ok with you? I am thinking about doing roll ups on health care in Australia but I am a little bit lost regarding what specific area. Please let me know if you can help. Cheers.
pfrholdings Happy to connect. However, in regards to healthcare services, I may not be helpful for Austrailia. The U.S. system is quite different vs. Canada/U.K./Austailia/New Zealand/Etc. - I have only ever really looked at HCIT businesses outside the U.S. However if you have any big questions, happy to try and be useful. Feel free to PM me.
No experience with healthcare rollups but am interested in eventually pursuing something like this.
Question I have for you: what other industries did you consider before deciding on healthcare? Could you talk a bit about why you ultimately decided against those other industries?
It was really a coincidence to be honest. I was not particularly interested in the sector and was actually working at a tech focused PE shop.
I got very interested in learning about the sector after seeing a business up for sale generating roughly 200k EBITDA for sale for 500k. I figured, there would probably more of these opportunities and started reading up about the industry. I then spoke to a more senior guy at a healthcare PE shop about my idea and he decided he wanted to partner with me on it.. and ive been cold calling businesses ever since (roughly 4months so far).
I encourage trying it. Its stressful as fuck and I had no idea what I was doing at first, but im starting to get the hang of cold calling entrepreneurs and convincing them to meet with me.
Curious about not only how its going (been about 2 years), but also did you see that initial business ($500k for $200k EBITDA) come up for sale on the business broker sites (BizBuySell and etc.) or a banker led process?
takenotes08 Thanks for your PM, I'm sorry to be a week late here, life has been busy.
I'm tight on time but from glancing through the thread, I think some of the later comments really unpacked the primary thing I could offer you.
If you aren't going into this with what I call a 'stem' asset lined up as the basis for your platform, you're doing it wrong. (Think of what a flower looks like.) Things may go well enough, but you've added an unnecessary burden on yourself.
You want a bigger player that you're forced to pay a higher multiple for simply due to where in the cap scale it sits. If you buy that 'stem' at (illustratively) 6x knowing that the space is highly fragmented and littered with businesses at 25-50% the EBITDA that you can scoop up at 4x, you can then go acquire the 'petals' and win on two counts.
One, those same dollars in EBITDA immediately enjoy the multiple of the 'stem' business. Two, you're often actually able to recognize some (typically quite moderate, don't model too bullishly here) cost synergies.
I don't know the healthcare space at all so I happily defer to everyone speaking with way more knowledge than me on billing cycles and such shit, but regardless of industry specifics, your cost synergies are invariably going to be lower than you think they'll be.
Either way, something as simple as 10% margin lift when paired with multiple expansion can create some really beautiful outcomes.
This gets really juicy if you're smart (or connected) and put a credit facility on the 'stem' business that allows you to fully finance your 'petal' acquisitions. This is easier done the farther apart in size your 'stem' and 'petal' businesses are.
Illustratively, one of the first real winners I had doing deals independently was a business with over $100m in revenue. It was one of two leaders in a fairly fragmented space (top three players were 10 acquisitions in either LOI or NDA on its own before I got to it. I was shocked to see that the multiples they were paying were literally half or less of their own multiple. Sure, it was all peanuts in terms of size, but wow, if all you had to do was go find two dozen tiny guys with $10-20m in revenue and bolt them on, that's easy. Paired with the 'stem' business's organic CAGR >25%, it was an easily financed deal (both the leverage for the 'stem' and an unfunded revolver). That one is currently printing money and I'm very fortunate for how that on my track record has helped my career unfold.
Hello, I just came across your post and thought I would reach out to you. I have been working on a similar project, but from the other end. I have identified a few targets, but am just beginning the process of raising capital. If you are open to discussing it, maybe we could collaborate. You can email me at [email protected]
Best wishes, Matt
Hit up Mike Pearson
You all make it sound so easy! Pick an industry that trades at 10x, roll-up small business at 3-5x. Why didn't I think of that?
OP's post is 2 years old, I wonder if he's a billionaire yet.
No, but I bought my first biz at 4x and have two other ones under LOI at 5-6x. Will be close to 2M EBITDA if we close both, but will still be cash poor since all cash is used to service debt and anything left is stacked to payout earnouts in 2 years.
For that first business you bought, have you found ways to improve EBITDa? We’re they’re any obvious / low hanging fruits? You said it’s healthcare services? US based?
bummp
Sint et ad accusantium ea iste magnam quaerat quia. Qui optio nesciunt repellat rerum ea et asperiores.
Est natus nemo sed rerum qui voluptatum. Voluptatem molestias autem et sit enim. Quo et quis quis at voluptatem qui. Provident similique dolor voluptatem itaque non. Dignissimos dignissimos omnis commodi distinctio quo voluptatem. Id recusandae deleniti repudiandae ut quae repellat.
Ipsa tempora a at suscipit autem. Distinctio est pariatur odio asperiores aut. Fugit corrupti id aperiam eum accusamus. Sequi dolor fugit hic culpa rem illum repellendus.
Repudiandae eos eos voluptas adipisci. Similique libero eaque vitae ad enim hic. Tempora tempore consequuntur cumque. Dignissimos corrupti quia ipsa sunt id. Officiis voluptatem quaerat vero neque. Perferendis unde iste tempore est delectus quas. Pariatur doloremque cum praesentium id laudantium nam.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Repellat quae modi dolor corrupti quia. Ipsa culpa nostrum et officiis tempore corporis. Est est in ad quisquam et eius.
Mollitia molestiae maiores sint quo omnis autem fugiat tempora. Id non adipisci aperiam facilis ducimus. Optio modi explicabo inventore. Nostrum doloremque velit soluta tempora perferendis facilis.
Iure quos vitae qui dolor in. Harum aut alias molestias amet occaecati ea excepturi est. Sit unde earum sed nobis et aut eius. Vel eligendi quisquam ex cupiditate sunt dolores. Consequatur nostrum soluta maxime sunt. Beatae magnam corrupti cupiditate. Cumque aut eum et sint laudantium.
Qui cum aut est quas quasi. Deserunt dolores cumque perspiciatis rerum. Occaecati neque ad commodi sapiente.